FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Robert Justice

Research Profile

Activities & Behaviors

Organizations

United States Food and Drug Administration

Geographic Areas

United States

Chemicals & Drugs

Procedures

Physiology

Drug Resistance, Neoplasm

Concepts & Ideas

Disorders

Gastrointestinal Stromal Tumors

Devices

Placebos

Co-author Network

Publications

TOP 3
Gideon M Blumenthal; Patricia Cortazar; Robert Justice; Anthony Murgo; R Sridhara; Shenghui Tang; Jenny J Zhang; Richard Pazdur
FDA approval summary: sunitinib for the treatment of progressive well-differentiated locally advanced or metastatic pancreatic neuroendocrine tumors.
Martin H Cohen; John R Johnson; Robert Justice; Richard Pazdur
Approval summary: imatinib mesylate for one or three years in the adjuvant treatment of gastrointestinal stromal tumors.
Marc R Theoret; Jenny J Zhang; Robert Justice; Patricia Keegan; Yang-Min Ning; Richard Pazdur
The risks and benefits of 5α-reductase inhibitors for prostate-cancer prevention.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Robert Justice (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Gideon M Blumenthal; Patricia Cortazar; Robert Justice; Anthony Murgo; R Sridhara; Shenghui Tang; Jenny J Zhang; Richard Pazdur
FDA approval summary: sunitinib for the treatment of progressive well-differentiated locally advanced or metastatic pancreatic neuroendocrine tumors.
The oncologist 2012;17(8):1108-13.
2012: Martin H Cohen; John R Johnson; Robert Justice; Richard Pazdur
Approval summary: imatinib mesylate for one or three years in the adjuvant treatment of gastrointestinal stromal tumors.
The oncologist 2012;17(7):992-7.
2011: Marc R Theoret; Jenny J Zhang; Robert Justice; Patricia Keegan; Yang-Min Ning; Richard Pazdur
The risks and benefits of 5α-reductase inhibitors for prostate-cancer prevention.
The New England journal of medicine 2011;365(2):97-9.
2011: John R Johnson; Yang-Min Ning; Ann Farrell; Robert Justice; Patricia Keegan; Richard Pazdur
Accelerated approval of oncology products: the food and drug administration experience.
Journal of the National Cancer Institute 2011;103(8):636-44.
2010: Shakun M Malik; Ke Liu; Xu Qiang; R Sridhara; Shenghui Tang; W David McGuinn; S Leigh Verbois; Anshu Marathe; Gene M Williams; Julie Bullock; Christoffer Tornoe; Sue Ching Lin; Terrance Ocheltree; Milinda Vialpando; Alice Kacuba; Robert Justice; Richard Pazdur
Folotyn (pralatrexate injection) for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma: U.S. Food and Drug Administration drug approval summary.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(20):4921-7.
2010: Martin H Cohen; Patricia Cortazar; Robert Justice; Richard Pazdur
Approval summary: pemetrexed maintenance therapy of advanced/metastatic nonsquamous, non-small cell lung cancer (NSCLC).
The oncologist 2010;15(12):1352-8.
2010: Martin H Cohen; John R Johnson; Somesh Chattopadhyay; Shenghui Tang; Robert Justice; R Sridhara; Richard Pazdur
Approval summary: erlotinib maintenance therapy of advanced/metastatic non-small cell lung cancer (NSCLC).
The oncologist 2010;15(12):1344-51.
2010: Michael Brave; Ann Farrell; Sue Ching Lin; Terrance Ocheltree; Sarah Pope Miksinski; Shwu-Luan Lee; Haleh Saber; Jeanne Fourie; Christoffer Tornoe; Brian Booth; Weishi Yuan; Kun He; Robert Justice; Richard Pazdur
FDA review summary: Mozobil in combination with granulocyte colony-stimulating factor to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation.
Oncology 2010;78(3-4):282-8.
2010: Martin H Cohen; Patricia Cortazar; Robert Justice; Richard Pazdur
Approval summary: imatinib mesylate in the adjuvant treatment of malignant gastrointestinal stromal tumors.
The oncologist 2010;15(3):300-7.
2009: Martin H Cohen; Robert Justice; Richard Pazdur
Approval summary: pemetrexed in the initial treatment of advanced/metastatic non-small cell lung cancer.
The oncologist 2009;14(9):930-5.
2009: Robert C Kane; Ann T Farrell; Rajanikanth Madabushi; Brian Booth; Somesh Chattopadhyay; R Sridhara; Robert Justice; Richard Pazdur
Sorafenib for the treatment of unresectable hepatocellular carcinoma.
The oncologist 2009;14(1):95-100.
2008: Maitreyee Hazarika; Edwin Rock; Gene Williams; Ramzi Dagher; R Sridhara; Brian Booth; Ann Farrell; Robert Justice; Richard Pazdur
Lenalidomide in combination with dexamethasone for the treatment of multiple myeloma after one prior therapy.
The oncologist 2008;13(10):1120-7.
2008: Qin Ryan; Amna Ibrahim; Martin H Cohen; John Johnson; Chia-wen Ko; R Sridhara; Robert Justice; Richard Pazdur
FDA drug approval summary: lapatinib in combination with capecitabine for previously treated metastatic breast cancer that overexpresses HER-2.
The oncologist 2008;13(10):1114-9.
2008: Maitreyee Hazarika; Xiaoping Jiang; Qi Liu; Shwu-Luan Lee; Roshni P Ramchandani; Christine Garnett; Micheal S Orr; R Sridhara; Brian Booth; John K Leighton; William Timmer; Ravi Harapanhalli; Ramzi Dagher; Robert Justice; Richard Pazdur
Tasigna for chronic and accelerated phase Philadelphia chromosome--positive chronic myelogenous leukemia resistant to or intolerant of imatinib.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(17):5325-31.
2008: Robert J Lechleider; Edvardas Kaminskas; Xiaoping Jiang; Robeena Aziz; Julie Bullock; Ravindra Kasliwal; Ravi Harapanhalli; Sarah Pope; R Sridhara; John Leighton; Brian Booth; Ramzi Dagher; Robert Justice; Richard Pazdur
Ixabepilone in combination with capecitabine and as monotherapy for treatment of advanced breast cancer refractory to previous chemotherapies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(14):4378-84.
2008: Robert C Kane; W David McGuinn; Ramzi Dagher; Robert Justice; Richard Pazdur
Dexrazoxane (Totect): FDA review and approval for the treatment of accidental extravasation following intravenous anthracycline chemotherapy.
The oncologist 2008;13(4):445-50.
2008: Michael Brave; Vicki Goodman; Edvardas Kaminskas; Ann Farrell; William Timmer; Sarah Pope; Ravi Harapanhalli; Haleh Saber; David Morse; Julie Bullock; Angela Men; Carol Noory; Roshni P Ramchandani; Leslie Kenna; Brian Booth; Jogarao V S Gobburu; Xiaoping Jiang; R Sridhara; Robert Justice; Richard Pazdur
Sprycel for chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to or intolerant of imatinib mesylate.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(2):352-9.
2007: Adrian M Senderowicz; John R Johnson; R Sridhara; Paul Zimmerman; Robert Justice; Richard Pazdur
Erlotinib/gemcitabine for first-line treatment of locally advanced or metastatic adenocarcinoma of the pancreas.
Oncology (Williston Park, N.Y.) 2007;21(14):1696-706; discussion 1706-9, 1712, 1715.
2007: Yang-Min Ning; Kun He; Ramzi Dagher; R Sridhara; Ann T Farrell; Robert Justice; Richard Pazdur
Liposomal doxorubicin in combination with bortezomib for relapsed or refractory multiple myeloma.
Oncology (Williston Park, N.Y.) 2007;21(12):1503-8; discussion 1511, 1513, 1516 passim.
2007: Bhupinder S Mann; John R Johnson; Martin H Cohen; Robert Justice; Richard Pazdur
FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma.
The oncologist 2007;12(10):1247-52.
2007: Robert C Kane; Ramzi Dagher; Ann Farrell; Chia-Wen Ko; R Sridhara; Robert Justice; Richard Pazdur
Bortezomib for the treatment of mantle cell lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(18 Pt 1):5291-4.
2007: Bhupinder S Mann; John R Johnson; Kun He; R Sridhara; Sophia Abraham; Brian P Booth; Leigh Verbois; David E Morse; Josephine M Jee; Sarah Pope; Ravi S Harapanhalli; Ramzi Dagher; Ann Farrell; Robert Justice; Richard Pazdur
Vorinostat for treatment of cutaneous manifestations of advanced primary cutaneous T-cell lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(8):2318-22.
2007: Vicki L Goodman; Edwin P Rock; Ramzi Dagher; Roshni P Ramchandani; Sophia Abraham; Jogarao V S Gobburu; Brian P Booth; S Leigh Verbois; David E Morse; Cheng Yi Liang; Nallaperumal Chidambaram; Janet X Jiang; Shenghui Tang; Kooros Mahjoob; Robert Justice; Richard Pazdur
Approval summary: sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(5):1367-73.
2007: Edwin P Rock; Vicki Goodman; Janet X Jiang; Kooros Mahjoob; S Leigh Verbois; David Morse; Ramzi Dagher; Robert Justice; Richard Pazdur
Food and Drug Administration drug approval summary: Sunitinib malate for the treatment of gastrointestinal stromal tumor and advanced renal cell carcinoma.
The oncologist 2007;12(1):107-13.
2006: Robert C Kane; Ann T Farrell; Haleh Saber; Shenghui Tang; Gene Williams; Josephine M Jee; Chengyi Liang; Brian Booth; Nallaperumal Chidambaram; David Morse; R Sridhara; Patricia Garvey; Robert Justice; Richard Pazdur
Sorafenib for the treatment of advanced renal cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(24):7271-8.
2006: Michael Brave; Ramzi Dagher; Ann Farrell; Sophia Abraham; Roshni P Ramchandani; Jogarao V S Gobburu; Brian Booth; Xiaoping Jiang; R Sridhara; Robert Justice; Richard Pazdur
Topotecan in combination with cisplatin for the treatment of stage IVB, recurrent, or persistent cervical cancer.
Oncology (Williston Park, N.Y.) 2006;20(11):1401-4, 1410; discussion 1410-11, 1415-6.
2006: Martin H Cohen; John R Johnson; Tristan Massie; R Sridhara; W David McGuinn; Sophia Abraham; Brian P Booth; M Anwar Goheer; David Morse; Xiao H Chen; Nallaperumal Chidambaram; Leslie Kenna; Jogarao V S Gobburu; Robert Justice; Richard Pazdur
Approval summary: nelarabine for the treatment of T-cell lymphoblastic leukemia/lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(18):5329-35.
1999: D L Clark; P A Andrews; D D Smith; JJ DeGeorge; Robert Justice; J G Beitz
Predictive value of preclinical toxicology studies for platinum anticancer drugs.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(5):1161-7.